- Home
- GSIW vs ANIX Comparison
GSIW vs ANIX Comparison
Compare GSIW & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- ANIX
- Stock Information
- Founded
- GSIW 2016
- ANIX 1982
- Country
- GSIW Hong Kong
- ANIX United States
- Employees
- GSIW N/A
- ANIX N/A
- Industry
- GSIW
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- GSIW
- ANIX Health Care
- Exchange
- GSIW Nasdaq
- ANIX Nasdaq
- Market Cap
- GSIW 104.6M
- ANIX 101.4M
- IPO Year
- GSIW 2023
- ANIX 1987
- Fundamental
- Price
- GSIW $1.52
- ANIX $2.99
- Analyst Decision
- GSIW
- ANIX Strong Buy
- Analyst Count
- GSIW 0
- ANIX 2
- Target Price
- GSIW N/A
- ANIX $8.50
- AVG Volume (30 Days)
- GSIW 7.2M
- ANIX 42.3K
- Earning Date
- GSIW 11-04-2024
- ANIX 10-29-2024
- Dividend Yield
- GSIW N/A
- ANIX N/A
- EPS Growth
- GSIW N/A
- ANIX N/A
- EPS
- GSIW N/A
- ANIX N/A
- Revenue
- GSIW $1,408,469.00
- ANIX N/A
- Revenue This Year
- GSIW N/A
- ANIX N/A
- Revenue Next Year
- GSIW N/A
- ANIX N/A
- P/E Ratio
- GSIW N/A
- ANIX N/A
- Revenue Growth
- GSIW N/A
- ANIX N/A
- 52 Week Low
- GSIW $1.04
- ANIX $2.15
- 52 Week High
- GSIW $15.99
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- GSIW 40.33
- ANIX 39.33
- Support Level
- GSIW $1.53
- ANIX $2.95
- Resistance Level
- GSIW $2.59
- ANIX $3.17
- Average True Range (ATR)
- GSIW 0.34
- ANIX 0.12
- MACD
- GSIW 0.19
- ANIX -0.02
- Stochastic Oscillator
- GSIW 11.57
- ANIX 12.90
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.